0001964306-24-000233.txt : 20240530
0001964306-24-000233.hdr.sgml : 20240530
20240530162536
ACCESSION NUMBER: 0001964306-24-000233
CONFORMED SUBMISSION TYPE: 144
PUBLIC DOCUMENT COUNT: 1
FILED AS OF DATE: 20240530
DATE AS OF CHANGE: 20240530
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: Y-mAbs Therapeutics, Inc.
CENTRAL INDEX KEY: 0001722964
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 474619612
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 144
SEC ACT: 1933 Act
SEC FILE NUMBER: 001-38650
FILM NUMBER: 241005712
BUSINESS ADDRESS:
STREET 1: 230 PARK AVENUE
STREET 2: SUITE 3350
CITY: NEW YORK
STATE: NY
ZIP: 10169
BUSINESS PHONE: 212-847-9841
MAIL ADDRESS:
STREET 1: 230 PARK AVENUE
STREET 2: SUITE 3350
CITY: NEW YORK
STATE: NY
ZIP: 10169
REPORTING-OWNER:
COMPANY DATA:
COMPANY CONFORMED NAME: Kruse Bo
CENTRAL INDEX KEY: 0001752940
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 144
MAIL ADDRESS:
STREET 1: C/O Y-MABS THERAPEUTICS, INC.
STREET 2: 230 PARK AVENUE, 33RD FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10169
144
1
primary_doc.xml
144
0001752940
XXXXXXXX
LIVE
0001722964
Y-mAbs Therapeutics, Inc.
001-38650
230 PARK AVENUE
SUITE 3350
NEW YORK
NY
10169
212-847-9841
Kruse Bo
Officer
Common Stock
Merrill Lynch
225 Liberty St
Floor 37
New York
NY
10281
60000
721960.44
43882638
05/30/2024
NASDAQ
Common Stock
05/30/2024
Exercise of employee stock options
Y-mAbs Therapeutics, Inc.
N
60000
05/30/2024
Broker assisted cashless exercise
Y
05/30/2024
Bo Kruse